|
89
|
230
|
3ookA |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluorobenzoic acid |
|
64
|
232
|
3ozjA |
Crystal structure of human retinoic x receptor alpha complexed with bigelovin and coactivator src-1 |
|
89
|
242
|
3os8C |
Estrogen receptor |
|
82
|
234
|
3omoA |
Fragment-based design of novel estrogen receptor ligands |
|
89
|
241
|
3os8A |
Estrogen receptor |
|
83
|
234
|
3ompA |
Fragment-based design of novel estrogen receptor ligands |
|
89
|
237
|
3ollA |
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain |
|
83
|
234
|
3omqA |
Fragment-based design of novel estrogen receptor ligands |
|
86
|
234
|
3olsA |
Crystal structure of estrogen receptor beta ligand binding domain |
|
97
|
272
|
3oswA |
Crystal structure of ppargamma ligand binding domain in complex with tetrabromo-bisphenol a (tbbpa) |
|
86
|
230
|
3ommA |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-fluorobenzoic acid |
|
88
|
228
|
3okhA |
Crystal structure of human fxr in complex with 2-(4-chlorophenyl)-1-[(1s)-1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]-1h-benzimidazole-6-carboxylic acid |
|
86
|
230
|
3olfA |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid |
|
62
|
235
|
3p0uA |
Crystal structure of the ligand binding domain of human testicular receptor 4 |
|
93
|
230
|
3oofA |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid |
|
87
|
230
|
3omkA |
Crystal structure of human fxr in complex with (2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexyl-n-(2-methylphenyl)ethanamide |
|
84
|
230
|
3okiA |
Crystal structure of human fxr in complex with (2s)-2-[2-(4-chlorophenyl)-1h-benzimidazol-1-yl]-n,2-dicyclohexylethanamide |
|
91
|
241
|
3osaA |
Estrogen receptor |
|
98
|
272
|
3osiA |
Crystal structure of ppargamma ligand binding domain in complex with tetrachloro-bisphenol a (tcbpa) |
|
91
|
300
|
3o1dA |
Structure-function study of gemini derivatives with two different side chains at c-20, gemini-0072 and gemini-0097. |
|
78
|
231
|
3oapA |
Crystal structure of human retinoid x receptor alpha-ligand binding domain complex with 9-cis retinoic acid and the coactivator peptide grip-1 |
|
91
|
300
|
3o1eA |
Structure-function of gemini derivatives with two different side chains at c-20, gemini-0072 and gemini-0097. |
|
61
|
193
|
3nsqA |
Crystal structure of tetrameric rxralpha-lbd complexed with antagonist danthron |
|
69
|
193
|
3nspA |
Crystal structure of tetrameric rxralpha-lbd |
|
103
|
271
|
3noaA |
Crystal structure of human ppar-gamma ligand binding domain complex with a potency improved agonist |
|
70
|
230
|
3n00A |
Crystal structure of a deletion mutant of human reverba ligand binding domain bound with an ncor id1 peptide determined to 2.60a |
|
100
|
257
|
3mnpA |
Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by (a611v, v708a, e711g) mutations at 1.50a |
|
103
|
258
|
3mnoA |
Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by (a611v, f608s) mutations at 1.55a |
|
100
|
258
|
3mneA |
Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by f608s mutation at 1.96a |
|
100
|
253
|
3m7rA |
Crystal structure of vdr h305q mutant |
|
103
|
271
|
3lmpA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
95
|
237
|
3lbdA |
Ligand-binding domain of the human retinoic acid receptor gamma bound to 9-cis retinoic acid |
|
97
|
247
|
3l0lA |
Crystal structure of orphan nuclear receptor rorgamma in complex with natural ligand |
|
79
|
230
|
3kwyA |
Crystal structure of rxralpha ligand binding domain in complex with triphenyltin and a coactivator fragment |
|
97
|
244
|
3l03A |
Crystal structure of human estrogen receptor alpha ligand-binding domain in complex with a glucocorticoid receptor interacting protein 1 nr box ii peptide and estetrol (estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol) |
|
89
|
231
|
3l1bA |
Complex structure of fxr ligand-binding domain with a tetrahydroazepinoindole compound |
|
88
|
243
|
3l0eA |
X-ray crystal structure of a potent liver x receptor modulator |
|
98
|
250
|
3l3xA |
Crystal structure of dht-bound androgen receptor in complex with the first motif of steroid receptor coactivator 3 |
|
93
|
243
|
3l0jA |
Crystal structure of orphan nuclear receptor rorgamma in complex with natural ligand |
|
94
|
243
|
3kytA |
Crystal structure of orphan nuclear receptor rorgamma in complex with natural ligand |
|
98
|
250
|
3l3zA |
Crystal structure of dht-bound androgen receptor in complex with the third motif of steroid receptor coactivator 3 |
|
93
|
234
|
3kmrA |
Crystal structure of raralpha ligand binding domain in complex with an agonist ligand (am580) and a coactivator fragment |
|
93
|
251
|
3kbaA |
Progesterone receptor bound to sulfonamide pyrrolidine partial agonist |
|
107
|
270
|
3kduA |
Crystal structure of peroxisome proliferator-activatedeceptor alpha (pparalpha) complex with n-3-((2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-n-((4-methylphenoxy)carbonyl)glycine |
|
88
|
221
|
3kmzA |
Crystal structure of raralpha ligand binding domain in complex with the inverse agonist bms493 and a corepressor fragment |
|
99
|
270
|
3kdtA |
Crystal structure of peroxisome proliferator-activatedeceptor alpha (pparalpha) complex with n-3-((2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-n-(methoxycarbonyl)glycine |
|
85
|
239
|
3kfcA |
Complex structure of lxr with an agonist |
|
97
|
253
|
3kpzA |
Crystal structure of a novel vitamin d3 analogue, zk203278 showing dissociated profile |
|
101
|
268
|
3kmgA |
The x-ray crystal structure of ppar-gamma in complex with an indole derivative modulator, gsk538, and an src-1 peptide |
|
92
|
251
|
3k22A |
Glucocorticoid receptor with bound alaninamide 10 with tif2 peptide |
